Jeff Lagasse
The company cites clinical expertise and service capabilities across the company, boosted by "disciplined execution."
Doctors' Management Services failed to determine the potential risks and vulnerabilities in the breach, HHS says.
A number of factors contributed to the company's financial performance, including the August launch of Cordavis and its MA offerings.
Nostrum admitted it acquired Nitro OS from another manufacturer and continued to market it based on its preexisting FDA approval.
Lack of transparency limits the ability of regulators to monitor prices and of employers and patients to impose market discipline on prices.
Final rule increases payment for certain new renal dialysis drugs and biological products.
The larger ACA plan footprint will bring access to affordable benefits to more than 60% of the eligible population, UHC says.
Benefits will now be distributed to the subscribers who sued Blue Cross more than a decade ago.
Groups with the highest gains in coverage because of Medicaid expansion include non-Hispanic Blacks, young adults and women.
A deal between Express Scripts and Prime Therapeutics served solely as a price-fixing mechanism, the suit alleges.